1. Summary Report Version 1.0 25 th June 2013 1

2. Contents 2 1.Finances and Recovery Plan 1.Cash position 2.2013/14 performance against plan 3.Cost run rate and CIP delivery update 2. Board governance 1.Governance review update 2.Executive capacity (e.g. substantive appointments) 3. EPR update 4. Mortality review report 5. A&E performance 1.Performance Q1 to date 2.Trajectory for recovery 6. AOB

3. Cash – 26 week cash flow forecast to November 2013 3

4. Consolidated trading results (Month 2 YTD) 4 Key points 1.Net Surplus / (Deficit) - £0.4m (£0.5m YTD) net favourable variance to plan in M2 driven by expenditure savings. 2.Clinical Income - £0.5m adverse variance to plan at M2 mainly due to shortfalls in Elective activity and £0.3m provision against receipt of CQUIN / Non-Recurrent income. 3.Other Operating Income – YTD adjustment in M2 reflects timing differences against 1/12ths plan profile and prudent approach to FY14 receipts not yet quantified. 4.Pay – Continued downward trend. Underlying run rate at £12.2m 5.Non Pay - £0.2m favourable variance to plan at M2 due to tactical cost controls and tight budgetary management.

5. Run rate analysis 5

6. Payroll Analysis 6

7. Contents 7 1.Finances and Recovery Plan 1.Cash position 2.2013/14 performance against plan 3.Cost run rate and CIP delivery update 2. Board governance 1.Governance review update 2.Executive capacity (e.g. substantive appointments) 3. EPR update 4. Mortality review report 5. A&E performance 1.Performance Q1 to date 2.Trajectory for recovery 6. AOB

8. Governance update 8 Following a mini-tender process, Deloitte were selected by the Trust to carry out the external governance review, with Jay Bevington as lead partner Monitor approved the scope and appointment of Deloitte Therefore Deloitte were commissions and the project commences Monday 24 th July 2013 Deloitte have committed to produce the final report and recommendations in line with the line with the deadline from the revised Monitor Enforcement Undertakings, i.e. final report by Wednesday 31 st July 2013 The report will be jointly addressed to the Trust and to Monitor Executive capacity (e.g. substantive appointments) Verbal update

9. Contents 9 1.Finances and Recovery Plan 1.Cash position 2.2013/14 performance against plan 3.Cost run rate and CIP delivery update 2. Board governance 1.Governance review update 2.Executive capacity (e.g. substantive appointments) 3. EPR update 4. Mortality review report 5. A&E performance 1.Performance Q1 to date 2.Trajectory for recovery 6. AOB

10. EPR Update The PID and project plan have now been finalised (see next slide and report) and signed off by Board Recent code drops have enhanced both usability, speed and reporting functions Re-configuration of the Health Informatics Directorate is now complete. Data Quality Team now in place and action plan being developed for both user inputting and coding improvements. Weekly project/team meetings to ensure project kept on track including Meditech and Filtek Regular additional meetings planned with Meditech Development lead to ensure continued resource allocation and support against the plan We continue to recruit to the team to ensure adequate resource to deliver the plan, additional clinical leads currently being advertised 10

11. 11

12. Contents 12 1.Finances and Recovery Plan 1.Cash position 2.2013/14 performance against plan 3.Cost run rate and CIP delivery update 2. Board governance 1.Governance review update 2.Executive capacity (e.g. substantive appointments) 3. EPR update 4. Mortality review report 5. A&E performance 1.Performance Q1 to date 2.Trajectory for recovery 6. AOB

13. Mortality Update Mortality figures reviewed and increasing trend identified. Investigation identified issues with (see report): Coding of palliative care epsiodes vs EoLife Primary and secondary diagnosis recording Depth of coding Activity reductions lowering the denominator Pneumonia cases review underway All actions re coding issues currently being completed –re- review of October to march data will be in July once all data available Regular monthly monitoring and quarterly monitoring underway 13

14. Contents 14 1.Finances and Recovery Plan 1.Cash position 2.2013/14 performance against plan 3.Cost run rate and CIP delivery update 2. Board governance 1.Governance review update 2.Executive capacity (e.g. substantive appointments) 3. EPR update 4. Mortality review report 5. A&E performance 1.Performance Q1 to date 2.Trajectory for recovery 6. AOB

15. A&E performance (for week ending 23 rd June 2013) Weekly Performance = 96.31% June Performance to date = 97.31% · 1519 attendances (inc 27 EPAUS) · 56 breaches · Average daily attendances for Mon-Fri = 215 for ED and 5 for EPAU · Average daily attendances for Sat-Sun = 208 for ED Qtr 1 and YTD performance = 93.93% 15

16. 16 A&E Recovery Trajectory to achieve 2013-14 target (Q2-4)

17. Contents 17 1.Finances and Recovery Plan 1.Cash position 2.2013/14 performance against plan 3.Cost run rate and CIP delivery update 2. Board governance 1.Governance review update 2.Executive capacity (e.g. substantive appointments) 3. EPR update 4. Mortality review report 5. A&E performance 1.Performance Q1 to date 2.Trajectory for recovery 6. AOB